Trials / Conditions / Marginal Zone Lymphomas
Marginal Zone Lymphomas
4 registered clinical trials studyying Marginal Zone Lymphomas — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma NCT07008053 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies NCT02362035 | Acerta Pharma BV | Phase 1 / Phase 2 |
| Active Not Recruiting | Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas NCT00877214 | Jurgen Barth | Phase 3 |
| Completed | Bendamustine Plus Rituximab Versus CHOP Plus Rituximab NCT00991211 | University of Giessen | Phase 3 |